Mindblown: a blog about philosophy.
-
Biodesix Announces Fourth Quarter and Fiscal Year End 2022 Results and Highlights
March 6, 2023 at 6:00 AM EST
-
Your Blog Post Title Here…
-
Biodesix to Participate at Cowen’s 43rd Annual Healthcare Conference
BOULDER, CO, February 28, 2023 – Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that Scott Hutton, Chief Executive Officer of Biodesix, will participate in a fireside chat and host in-person 1×1 investor meetings at Cowen’s 43rd Annual Healthcare Conference being held from March 6-8,…
-
Biodesix to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023
February 21, 2023 at 6:00 AM EST
-
Biodesix Announces First Four Private Payer Coverage Policies for the Nodify XL2® Test
Boulder, CO.–(BUSINESS WIRE)–December 19, 2022 – Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced positive coverage decisions from four private payers including Blue Cross Blue Shield of North Carolina, Blue Cross Blue Shield of South Carolina, Blue Cross Blue Shield of Kansas City, and Capital…
-
Biodesix Announces Appointment of Lawrence (Lair) T. Kennedy, Jr. to Board of Directors
Boulder, CO.–(BUSINESS WIRE)–December 16, 2022 – Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced the appointment of Lawrence (Lair) T. Kennedy, Jr. to the Company’s Board of Directors (Board) and Audit Committee of the Board effective January 3, 2023. Mr. Kennedy brings to Biodesix more…
-
Biodesix Ranked Top Proteomics Solutions Company by Life Sciences Review Magazine
December 12, 2022 at 6:00 AM EST
-
Biodesix Announces Pricing of $35.1 Million Upsized Public Offering of Common Stock
November 17, 2022 at 12:26 AM EST
-
Biodesix Announces Proposed Public Offering of Common Stock
November 16, 2022 at 4:05 PM EST
-
Biodesix Announces Senior Secured Financing Agreement with Perceptive Advisors for Up to $50 Million
November 16, 2022 at 4:01 PM EST
Got any book recommendations?